Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Larimar Therapeutics, Inc. | zfgn-ex321_9.htm |
| EX-31.2 - EX-31.2 - Larimar Therapeutics, Inc. | zfgn-ex312_8.htm |
| EX-31.1 - EX-31.1 - Larimar Therapeutics, Inc. | zfgn-ex311_6.htm |
| EX-23.1 - EX-23.1 - Larimar Therapeutics, Inc. | zfgn-ex231_7.htm |
| EX-10.35 - EX-10.35 - Larimar Therapeutics, Inc. | zfgn-ex1035_169.htm |
| EX-10.28 - EX-10.28 - Larimar Therapeutics, Inc. | zfgn-ex1028_415.htm |
| EX-4.3 - EX-4.3 - Larimar Therapeutics, Inc. | zfgn-ex43_80.htm |
| 10-K - 10-K - Larimar Therapeutics, Inc. | zfgn-10k_20191231.htm |
Exhibit 21.1
SUBSIDIARIES
|
|
|
|
|
|
|
|
|
Subsidiary |
|
Jurisdiction of |
|
1 |
|
Zafgen Securities Corporation |
|
Massachusetts |
|
2 |
|
Zafgen Australia Pty Limited |
|
Australia |
|
3 |
|
Zafgen Animal Health, LLC |
|
Delaware |
|
4 |
|
Zordich Merger Sub, Inc. |
|
Delaware |